Evidence map›Paper›PMID 34376103›Full record

ArticleInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2021

Deployable ultrasound applicators for endoluminal delivery of volumetric hyperthermia.

Muhammad Zubair, Matthew S Adams, Chris J Diederich

Abstract read
In one paragraph

Article in International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad ZubairThermal Therapy Research Group, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Matthew S AdamsThermal Therapy Research Group, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
Chris J DiederichThermal Therapy Research Group, Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.

Funding

Deployable Ultrasound Applicators for MRI Guided Thermal Therapy of Pancreatic CancerR01EB025990 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIEDERICH, CHRIS JOHN · 2018 to 2022
$2.2M
Deployable Endoluminal Ultrasound Phased Array for Precision Treatment of Pancreatic CancerR21CA230120 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIEDERICH, CHRIS JOHN · 2018 to 2019
$377k
NCI NIH HHS R21 CA230120NIBIB NIH HHS R01 EB025990
6 · The paper itself

Abstract

purposeTo investigate the design of an endoluminal deployable ultrasound applicator for delivering volumetric hyperthermia to deep tissue sites as a possible adjunct to radiation and chemotherapy.

methodThis study considers an ultrasound applicator consisting of two tubular transducers situated at the end of a catheter assembly, encased within a distensible conical shaped balloon-based reflector that redirects acoustic energy distally into the tissue. The applicator assembly can be inserted endoluminally or laparoscopically in a compact form and expanded after delivery to the target site. Comprehensive acoustic and biothermal simulations and parametric studies were employed in generalized 3D and patient-specific pancreatic head and body tumor models to characterize the acoustic performance and evaluate heating capabilities of the applicator by investigating the device at a range of operating frequencies, tissue acoustic and thermal properties, transducer configurations, power modulation, applicator positioning, and by analyzing the resultant 40, 41, and 43 °C isothermal volumes and penetration depth of the heating volume. Intensity distributions and volumetric temperature contours were calculated to define moderate hyperthermia boundaries.

resultsParametric studies demonstrated the frequency selection to control volume and depth of therapeutic heating from 62 to 22 cm

conclusion

Indexed as

Hyperthermia, InducedUltrasonic TherapyEquipment DesignHumansHyperthermiaTransducersUltrasonographyendoluminal ultrasound applicatorpancreatic cancertargeted drug deliverythermal therapyUltrasound hyperthermia

Identifiers

PMID34376103
PMCPMC8802621

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.